# Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention

> **NCT02896712** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 118 (actual)

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **BEHAVIORAL:** Acceptance and Commitment Therapy (ACT)
- **BEHAVIORAL:** Drug Counseling (DC)
- **BEHAVIORAL:** Contingency Management (CM)
- **DRUG:** Placebo
- **DRUG:** Modafinil

## Key facts

- **NCT ID:** NCT02896712
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-18
- **Primary completion:** 2021-09-13
- **Final completion:** 2021-09-13
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02896712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02896712, "Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02896712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*